<html>
<head>PUBMED IDs for ZNF300</head>
<body bgcolor='#C5F0F2'><h1>ZNF300</h1><a href='https://pubmed.ncbi.nlm.nih.gov/14746915/'>Identification and functional analysis of a novel human KRAB/C2H2 zinc finger gene ZNF300.</a> January 30  2004<br><a href='https://pubmed.ncbi.nlm.nih.gov/17541838/'>Molecular cloning and characterization of a novel splice variant of human ZNF300 gene, which expressed highly in testis.</a> June 2  2007<br><a href='https://pubmed.ncbi.nlm.nih.gov/18350257/'>Identification of the DNA binding element of the human ZNF300 protein.</a> March 20  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/18350256/'>Analysis of RAB27A gene in griscelli syndrome type 2: novel mutations including a deletion hotspot.</a> March 20  2008<br><a href='https://pubmed.ncbi.nlm.nih.gov/20106866/'>Independent and population-specific association of risk variants at the IRGM locus with Crohn's disease.</a> August 26  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20471086/'>PU.1 can regulate the ZNF300 promoter in APL-derived promyelocytes HL-60.</a> December 22  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20471070/'>Identification of TNF-related apoptosis-inducing ligand and other molecules that distinguish inflammatory from resident dendritic cells in patients with psoriasis.</a> August 25  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20471067/'>The predictive value of serum VEGF in multiresistant ovarian cancer patients treated with bevacizumab.</a> July 23  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/20585888/'>ZNF300, a recently identified human transcription factor, activates the human IL-2RÎ² promoter through the overlapping ZNF300/EGR1 binding site.</a> January 14  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/21777376/'>Overexpression of the human ZNF300 gene enhances growth and metastasis of cancer cells through activating NF-kB pathway.</a> September 18  2011<br><a href='https://pubmed.ncbi.nlm.nih.gov/24393131/'>ZNF300P1 encodes a lincRNA that regulates cell polarity and is epigenetically silenced in type II epithelial ovarian cancer.</a> September 10  2014<br></body></html>
